Cambridge Trust Co. raised its position in shares of Aptiv PLC (NYSE:APTV – Free Report) by 24.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 111,662 shares of the auto parts company’s stock after purchasing an additional 22,258 shares during the period. Cambridge Trust Co.’s holdings in Aptiv were worth $10,018,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of APTV. Salem Investment Counselors Inc. grew its stake in shares of Aptiv by 176.0% in the second quarter. Salem Investment Counselors Inc. now owns 276 shares of the auto parts company’s stock worth $25,000 after purchasing an additional 176 shares during the last quarter. Turtle Creek Wealth Advisors LLC bought a new stake in Aptiv during the 4th quarter valued at approximately $29,000. FWL Investment Management LLC bought a new stake in Aptiv during the 4th quarter valued at approximately $30,000. BluePath Capital Management LLC bought a new stake in Aptiv during the 3rd quarter valued at approximately $55,000. Finally, KB Financial Partners LLC bought a new stake in Aptiv during the 1st quarter valued at approximately $56,000. 94.21% of the stock is owned by institutional investors.
Aptiv Stock Performance
APTV traded down $0.23 during midday trading on Thursday, reaching $69.12. The company had a trading volume of 918,410 shares, compared to its average volume of 2,679,619. The company has a quick ratio of 1.22, a current ratio of 1.72 and a debt-to-equity ratio of 0.53. The business has a 50-day moving average of $77.91 and a two-hundred day moving average of $82.67. The company has a market cap of $18.85 billion, a P/E ratio of 6.78, a P/E/G ratio of 0.93 and a beta of 1.90. Aptiv PLC has a 1 year low of $68.84 and a 1 year high of $113.60.
Analyst Ratings Changes
Several equities research analysts have commented on APTV shares. Piper Sandler dropped their target price on Aptiv from $80.00 to $79.00 and set a “neutral” rating on the stock in a report on Thursday, February 1st. Royal Bank of Canada dropped their target price on Aptiv from $115.00 to $104.00 and set an “outperform” rating on the stock in a report on Thursday, February 1st. Citigroup decreased their price target on Aptiv from $150.00 to $136.00 and set a “buy” rating for the company in a research note on Thursday, February 1st. Oppenheimer reduced their price objective on Aptiv from $149.00 to $148.00 and set an “outperform” rating for the company in a research report on Thursday, February 1st. Finally, UBS Group upped their price objective on Aptiv from $107.00 to $110.00 in a research report on Monday, April 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat.com, Aptiv presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.36.
Read Our Latest Research Report on Aptiv
Insider Transactions at Aptiv
In other Aptiv news, SVP Benjamin Lyon sold 18,680 shares of the firm’s stock in a transaction on Monday, March 11th. The stock was sold at an average price of $77.69, for a total transaction of $1,451,249.20. Following the transaction, the senior vice president now directly owns 95,211 shares in the company, valued at approximately $7,396,942.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.34% of the company’s stock.
Aptiv Company Profile
Aptiv PLC engages in design, manufacture, and sale of vehicle components in North America, Europe, Middle East, Africa, the Asia Pacific, South America, and internationally. The company provides electrical, electronic, and safety technology solutions to the automotive and commercial vehicle markets. It operates through two segments, Signal and Power Solutions, and Advanced Safety and User Experience.
Recommended Stories
- Five stocks we like better than Aptiv
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Comprehensive PepsiCo Stock Analysis
- 3 Healthcare Dividend Stocks to Buy
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Bear Market Funds to Watch This Year
Receive News & Ratings for Aptiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptiv and related companies with MarketBeat.com's FREE daily email newsletter.